PG
PEAK6 Group’s BioMarin Pharmaceuticals BMRN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | $8.24M | Sell |
87,517
-28,857
| -25% | -$2.72M | 0.04% | 76 |
|
|
2018
Q1 | $9.43M | Buy |
116,374
+59,510
| +105% | +$4.82M | 0.04% | 75 |
|
|
2017
Q4 | $5.07M | Buy |
56,864
+36,698
| +182% | +$3.27M | 0.02% | 130 |
|
|
2017
Q3 | $1.88M | Buy |
20,166
+9,162
| +83% | +$853K | 0.01% | 254 |
|
|
2017
Q2 | $999K | Sell |
11,004
-48,970
| -82% | -$4.45M | 0.01% | 394 |
|
|
2017
Q1 | $5.27M | Buy |
59,974
+34,417
| +135% | +$3.02M | 0.04% | 90 |
|
|
2016
Q4 | $2.12M | Buy |
+25,557
| New | +$2.12M | 0.02% | 244 |
|
|
2016
Q3 | – | Sell |
-11,193
| Closed | -$871K | – | 1073 |
|
|
2016
Q2 | $871K | Buy |
+11,193
| New | +$871K | 0.01% | 286 |
|
|
2016
Q1 | – | Sell |
-42,706
| Closed | -$4.47M | – | 1030 |
|
|
2015
Q4 | $4.47M | Sell |
42,706
-25,812
| -38% | -$2.7M | 0.03% | 134 |
|
|
2015
Q3 | $7.22M | Buy |
68,518
+9,456
| +16% | +$996K | 0.04% | 105 |
|
|
2015
Q2 | $8.08M | Buy |
59,062
+39,407
| +200% | +$5.39M | 0.05% | 89 |
|
|
2015
Q1 | $2.45M | Buy |
+19,655
| New | +$2.45M | 0.02% | 213 |
|
|
2014
Q4 | – | Sell |
-41,549
| Closed | -$3M | – | 1284 |
|
|
2014
Q3 | $3M | Buy |
41,549
+20,549
| +98% | +$1.48M | 0.02% | 262 |
|
|
2014
Q2 | $1.31M | Buy |
21,000
+11,500
| +121% | +$715K | 0.01% | 351 |
|
|
2014
Q1 | $648K | Buy |
9,500
+100
| +1% | +$6.82K | 0.01% | 632 |
|
|
2013
Q4 | $661K | Buy |
+9,400
| New | +$661K | ﹤0.01% | 636 |
|
|
2013
Q3 | – | Sell |
-2,500
| Closed | -$139 | – | 1505 |
|
|
2013
Q2 | $139 | Buy |
+2,500
| New | +$139 | ﹤0.01% | 1021 |
|